EP1586558A3
Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
Abstract
Bis-sulfonamido hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to retroviral protease inhibiting compounds of the formula: or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein the variables are as defined herein.
Term
Term ended
Projected expiry passed 18 January 2016, 10.7 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO9404491A1 | Cites | World Intellectual Property Organization (WIPO) | A | Search report | 1,10,11 |
| WO9404493A1 | Cites | World Intellectual Property Organization (WIPO) | DA | Search report | 1,10,11 |
24 members in 9 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 376337 | United States of America | – | |
| 37633795 | United States of America | A | |
| 37633795 | United States of America | A | |
| 96902700 | European Patent Office (EPO) | A | |
| 96902700 | European Patent Office (EPO) | A | |
| 376337 | – | – | – |
| 96902700 | – | – | – |
| EP19960902700 | – | – | – |
| US19950376337 | – | – | – |
Members24
| Document | Office | Kind | |
|---|---|---|---|
| CA2210889A1 | Canada | A1 | |
| WO9622287A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4700896A | Australia | A | |
| EP0804428A1 | European Patent Office (EPO) | A1 | |
| JPH11500105A | Japan | A | |
| US6143747A | United States of America | A | |
| US6384036B1 | United States of America | B1 | |
| US2003013751A1 | United States of America | A1 | |
| US6569882B2 | United States of America | B2 | |
| US2004063771A1 | United States of America | A1 | |
| EP1586558A2 | European Patent Office (EPO) | A2 | |
| EP1586558A3This record | European Patent Office (EPO) | A3 | |
| US7091219B2 | United States of America | B2 | |
| US2006199822A1 | United States of America | A1 | |
| CA2210889C | Canada | C | |
| US7297793B2 | United States of America | B2 | |
| JP4014220B2 | Japan | B2 | |
| EP0804428B1 | European Patent Office (EPO) | B1 | |
| AT382041T | Austria | T | |
| ATE382041T1 | Austria | T1 | |
| DE69637380D1 | Germany | D1 | |
| US2008176842A1 | United States of America | A1 | |
| ES2303337T3 | Spain | T3 | |
| DE69637380T2 | Germany | T2 |
18 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| Title (correction)BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORSRTI1 | RTI1 | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| First examination report despatched17Q | 17Q | EP | |
| Designation fees paidAKX | AKX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1586558
- Publication, DOCDB
- 1586558
- Publication, EPODOC
- EP1586558
- Application
- 5013695
- Application, DOCDB
- 05013695
- Application, EPODOC
- EP20050013695
Titles3
- German
- Bis-sulfonamid-hydroxyethylamino-Derivate als Inhibitoren retroviraler Proteasen
- English
- Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
- French
- Inhibiteurs hydroxyethylamino contenant des bis-sulfinamides utilises pour inhiber des proteases retrovirales
Classification
- CPC, 13
- C07C311/29
- C07D235/26
- C07D235/32
- C07D277/82
- C07D295/26
- C07D307/79
- C07D317/62
- C07D319/18
- C07D405/12
- A61P31/12
- A61P31/14
- A61P31/18
- A61P43/00
- IPC, 55
- C07D295 08
- A61K31 18
- A61K31 185
- A61K31 195
- A61K31 335
- A61K31 336
- A61K31 34
- A61K31 341
- A61K31 343
- A61K31 357
- A61K31 36
- A61K31 38
- A61K31 381
- A61K31 40
- A61K31 4025
- A61K31 415
- A61K31 4184
- A61K31 42
- A61K31 423
- A61K31 425
- A61K31 428
- A61K31 443
- A61K31 445
- A61K31 454
- A61K31 495
- A61K31 496
- A61K31 535
- A61K31 5355
- A61K31 5375
- A61K31 5377
- A61P31 12
- A61P43 00
- C07C311 29
- C07C311 38
- C07D213 38
- C07D233 54
- C07D233 61
- C07D235 06
- C07D235 26
- C07D235 30
- C07D235 32
- C07D263 54
- C07D277 66
- C07D277 82
- C07D295 12
- C07D295 22
- C07D295 26
- C07D303 36
- C07D307 14
- C07D307 79
- C07D317 62
- C07D319 18
- C07D333 34
- C07D405 12
- C07D417 12
Designated states1
- Contracting states, 1
- Sweden